4//SEC Filing
Alder Matthias 4
Accession 0001104659-23-126020
CIK 0001819411other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:01 PM ET
Size
5.4 KB
Accession
0001104659-23-126020
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
2023-12-07$2.50/sh−1,820$4,550→ 4,855 total
Footnotes (2)
- [F1]Reflects shares sold to cover withholding taxes incurred upon the vesting and settlement of restricted stock units in a trade that was initiated by the Issuer on the Reporting Person's behalf.
- [F2]The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.48 to $2.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001370820
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:01 PM ET
- Size
- 5.4 KB